Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L

被引:117
作者
Rong, R
Tang, XL
Gutmann, DH
Ye, KQ
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[2] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
关键词
D O I
10.1073/pnas.0405971102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neurofibromatosis 2 (NF2) is a tumor suppressor, although the molecular mechanism accounting for this effect remains unknown. Here, we show that merlin exerts its activity by inhibiting phosphatidylinositol 3-kinase (P13-kinase), through binding to PIKE-L. Wild-type merlin, but not patient-derived mutant (L64P), binds PIKE-L and inhibits P13-kinase activity. This suppression of P13-kinase activity results from merlin disrupting the binding of PIKE-L to P13-kinase. In addition, merlin suppression of P13-kinase activity as well as schwannoma cell growth is abrogated by a single PIKE-L point mutation (P187L) that cannot bind merlin but can still activate P13-kinase. Knocking down PIKE-L with RNA interference abolishes merlin's tumor-suppressive activity. Our data support the hypothesis that PIKE-L is an important mediator of merlin growth suppression.
引用
收藏
页码:18200 / 18205
页数:6
相关论文
共 44 条
[1]   PIKE (Phosphatidylinositol 3-Kinase Enhancer)-A GTPase stimulates akt activity and mediates cellular invasion [J].
Ahn, JY ;
Rong, R ;
Kroll, TG ;
Van Meir, EG ;
Snyder, SH ;
Ye, KQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) :16441-16451
[2]  
Eldridge R, 1981, Adv Neurol, V29, P57
[3]   Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway [J].
Gautreau, A ;
Poullet, PR ;
Louvard, D ;
Arpin, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7300-7305
[4]   Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF [J].
Gonzalez-Agosti, C ;
Wiederhold, T ;
Herndon, ME ;
Gusella, J ;
Ramesh, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :34438-34442
[5]  
GonzalezAgosti C, 1996, ONCOGENE, V13, P1239
[6]   Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins [J].
Goutebroze, L ;
Brault, E ;
Muchardt, C ;
Camonis, J ;
Thomas, G .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1699-1712
[7]   Molecular insights into neurofibromatosis 2 [J].
Gutmann, DH .
NEUROBIOLOGY OF DISEASE, 1997, 3 (04) :247-261
[8]   Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading [J].
Gutmann, DH ;
Sherman, L ;
Seftor, L ;
Haipek, C ;
Lu, KH ;
Hendrix, M .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :267-275
[9]   Defects in neurofibromatosis 2 protein function can arise at multiple levels [J].
Gutmann, DH ;
Geist, RT ;
Xu, HM ;
Kim, JS ;
Saporito-Irwin, S .
HUMAN MOLECULAR GENETICS, 1998, 7 (03) :335-345
[10]   The neurofibromatoses: when less is more [J].
Gutmann, DH .
HUMAN MOLECULAR GENETICS, 2001, 10 (07) :747-755